All Things Considered
Since its debut in 1971, this afternoon radio newsmagazine has delivered in-depth reporting and transformed the way listeners understand current events and view the world. All Things Considered is one of the most popular programs in America. Every weekday, the program present two hours of breaking news mixed with compelling analysis, insightful commentaries, interviews, and special - sometimes quirky - features. A one-hour edition of the program is produced on the weekend.
Airs on KQED Public Radio Mon-Thu at 4:30 pm, Friday at 5:00 pm.
TPP and Pharma
A big sticking point in the negotiations over the Trans-Pacific Partnership involved biologics medicines and vaccines created from living organisms. The dispute centered on patent protection: how many years drug companies should have before facing competition from generics. The negotiators ended up with a complicated compromise that gives drug makers five to eight years of protection. But nobody is really happy with the outcome.